Terumo Cardiovascular Systems to Bring 65 New Jobs to Ann Arbor plant
Terumo Cardiovascular Systems (Terumo CVS) announced that it will bring 65 new jobs and $3.5 million in capital investments to its Ann Arbor location as a result of an incentive program offered by the Michigan Economic Development Corporation (MEDC). The company will transfer R&D and manufacturing operations from a plant in California to its Ann Arbor facility over the next nine months. The majority of the new jobs associated with the transfer will be created by 2010 with the remainder in place by 2014. The 65 new jobs represent a 20% increase to the company's existing local headcount.
Terumo CVS manufactures and markets a wide range of medical devices that are used in cardiac and vascular surgery. Currently, it develops and manufactures a highly specialized line of intraoperative monitoring products in California's Orange County. Those operations will be moved to Ann Arbor where Terumo CVS already manufactures electromechanical devices — including its market-leading line of heart-lung machines — and a line of sterile products.
"If you know somebody who has ever had heart surgery, it's very likely that their life depended on a heart-lung machine made here in Ann Arbor. We've had a world-class manufacturing operation here for decades," says Mark Sutter, President and CEO. "Consolidating more of our manufacturing in Ann Arbor gives us the opportunity to gain operational efficiencies while taking advantage of the great labor pool in southeast Michigan."
The transferred jobs will include technical, professional, and manufacturing positions. To accommodate the new operations, Terumo CVS will expand its existing facilities and construct a new chemistry lab.
The company's line of intraoperative monitoring products provides continuous information on important blood parameters during cardiac surgery. They have been used in over a million heart surgeries worldwide, are used by surgery teams in nine of the top ten US heart hospitals (hospitals ranked by US News and World Report, 2007), and, in the U.S.are used in virtually all pediatric cardiac surgeries because blood parameters can fluctuate quickly and more dramatically in very small patients.
Overall, Terumo CVS estimates that its products are used in more than 1000 cardiac and vascular surgeries daily, including coronary artery bypass grafting, valve replacements, heart transplants, aortic aneurysm repair, and surgeries for peripheral artery disease.
"Our plan is to continue double digit growth in the cardiac and vascular surgery market by adding new product lines and continuing to increase our market share in our existing product lines," says Sutter.
Terumo Cardiovascular Systems Corporation is a global manufacturer and marketer of medical devices for cardiac and vascular surgery. The company is headquartered in Ann Arbor, Michigan with manufacturing operations in Ann Arbor; Elkton, Maryland; Ashland, Massachusetts; and California. It is one of several subsidiaries of Terumo Corporation of Japan focused exclusively on the cardiac and vascular markets, including Terumo Heart Inc., developer of a ventricular assist device, and Vascutek Ltd, leading manufacturer of vascular grafts. For more information, visit www.terumo-cvs.com.
Terumo Corporation is a premier global medical device company with annual sales of nearly three billion dollars for the year ending March 31, 2008. Founded in 1921, the company develops, manufactures and distributes world-class medical devices for use in cardiothoracic surgery, interventional procedures, transfusion medicine, and needle and syringe products.